Cargando…

Uremia causes premature ageing of the T cell compartment in end-stage renal disease patients

BACKGROUND: End-stage renal disease (ESRD) patients treated with renal replacement therapy (RRT) have premature immunologically aged T cells which may underlie uremia-associated immune dysfunction. The aim of this study was to investigate whether uremia was able to induce premature ageing of the T c...

Descripción completa

Detalles Bibliográficos
Autores principales: Meijers, Ruud WJ, Litjens, Nicolle HR, de Wit, Elly A, Langerak, Anton W, van der Spek, Ashley, Baan, Carla C, Weimar, Willem, Betjes, Michiel GH
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482595/
https://www.ncbi.nlm.nih.gov/pubmed/22971545
http://dx.doi.org/10.1186/1742-4933-9-19
Descripción
Sumario:BACKGROUND: End-stage renal disease (ESRD) patients treated with renal replacement therapy (RRT) have premature immunologically aged T cells which may underlie uremia-associated immune dysfunction. The aim of this study was to investigate whether uremia was able to induce premature ageing of the T cell compartment. For this purpose, we examined the degree of premature immunological T cell ageing by examining the T cell differentiation status, thymic output via T cell receptor excision circle (TREC) content and proliferative history via relative telomere length in ESRD patients not on RRT. RESULTS: Compared to healthy controls, these patients already had a lower TREC content and an increased T cell differentiation accompanied by shorter telomeres. RRT was able to enhance CD8(+) T cell differentiation and to reduce CD8(+) T cell telomere length in young dialysis patients. An increased differentiation status of memory CD4(+) T cells was also noted in young dialysis patients. CONCLUSION: Based on these results we can conclude that uremia already causes premature immunological ageing of the T cell system and RRT further increases immunological ageing of the CD8(+) T cell compartment in particular in young ESRD patients.